Hydrochloric Acid

Hydrochloric Acid

SCHEMBL571004

CCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O.Cl

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 11/20 0.65
▸ SLC6A5 Q9Y345 2/20 0.56
▸ EPHX2 P34913 3/20 0.54
▸ GLP1R P43220 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20582736 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2GLP1R
Hydrochloric Acid SCHEMBL28043795 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2340732 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2343614 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL19499060 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL2344383 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL11102827 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL359523 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL11102825 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R
SCHEMBL539142 0.99 NOD1 (0.66) NOD1SLC6A5EPHX2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119235765-A Injectable hydrogel system and preparation method and application thereof 浙江理工大学嵊州创新研究院有限公司 2025-01-03 — — CN claimed
CN-109330902-A A kind of moisturizing is spraying and preparation method thereof 广州无添加主义化妆品有限公司 2019-02-15 — — CN claimed
CN-105037216-A Preparing method for lauroyl arginine monohydrochloride SHANGHAI INST TECHNOLOGY 2015-11-11 — — CN claimed
EP-2621460-A2 PRESERVATIVE AGENT COMPOSITIONS AND COSMETICS CONTAINING SAME Henkel AG & Co. KGaA (DE) 2013-08-07 — — EP claimed
WO-2012017091-A2 PRESERVATIVE AGENT COMPOSITIONS AND COSMETICS CONTAINING SAME HENKEL AG & CO. KGAA (DE) 2012-02-09 — — WO claimed
CN-119235765-A Injectable hydrogel system and preparation method and application thereof 浙江理工大学嵊州创新研究院有限公司 2025-01-03 — — CN disclosed
CN-116195767-A Cigarette filter tip and preparation process thereof 重庆中烟工业有限责任公司 2023-06-02 — — CN disclosed
US-11590743-B2 Active polystyrene film VISCOFAN, S.A. (ES) 2023-02-28 — — US disclosed
EP-3702406-B1 ACTIVE POLYSTYRENE FILM VISCOFAN SA (ES) 2022-12-07 — — EP disclosed
US-20220370332-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL HENKEL AG & CO. KGAA (DE) 2022-11-24 — — US disclosed
EP-3702406-A1 ACTIVE POLYSTYRENE FILM Viscofan, S.A. (ES) 2020-09-02 — — EP disclosed
US-20200269557-A1 ACTIVE POLYSTYRENE FILM VISCOFAN, S.A. (ES) 2020-08-27 — — US disclosed
WO-2013091976-A2 FOAMABLE COSMETIC PRODUCT FOR SKIN CARE HENKEL AG & CO. KGAA (DE) 2013-06-27 — — WO disclosed
WO-2013091978-A2 PRESERVATIVE COMPOSITION AND COSMETIC PRODUCTS CONTAINING SAME HENKEL AG & CO. KGAA (DE) 2013-06-27 — — WO disclosed
WO-2012017091-A2 PRESERVATIVE AGENT COMPOSITIONS AND COSMETICS CONTAINING SAME HENKEL AG & CO. KGAA (DE) 2012-02-09 — — WO disclosed
EP-1937830-A2 STABILIZED ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS OF PREPARATION University of Massachusetts (US) 2008-07-02 — — EP disclosed
EP-1912507-A2 METHOD AND APPARATUS FOR TREATMENT OF FOOD PRODUCTS The United States of America, as represented by the Secretary ofd Agrigulture (US) 2008-04-23 — — EP disclosed
US-20070082018-A1 Stabilized antimicrobial compositions and related methods of preparation UNIVERSITY OF MASSACHUSETTS 2007-04-12 — — US disclosed
WO-2007038627-A2 STABILIZED ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS OF PREPARATION UNIVERSITY OF MASSACHUSETTS (US) 2007-04-05 — — WO disclosed
WO-2007005410-A2 METHOD AND APPARATUS FOR TREATMENT OF FOOD PRODUCTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2007-01-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220370332-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND, PRESERVATIVE AND ETHOXYLATED FATTY ALCOHOL FABP4, ANXA4, OR51E2 NOD1 4738/4885SLC6A5 3618/4885EPHX2 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback